Cargando…
JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial
This study observed the efficacy and safety of JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) for pre-diabetes. Four hundred patients with pre-diabetes at five centres were treated for 12months and followed for an additional 12months to investigate the preventative effe...
Autores principales: | Wang, Hui, Guo, Liping, Shang, Hongcai, Ren, Ming, Wang, Xuemei, Wang, Dehui, Chen, Jianzong, Li, Shuanglei, Chen, Liming, Wang, Yue, Liu, Zhi, Zhai, Jingbo, Song, Yuzhen, Cao, Hongbo, Zhang, Junhua, Liu, Chunxiang, Sun, Xiao, Huo, Da, Mu, Wei, Zhang, Li, Zheng, Wenke, Yan, Xiaoyan, Yao, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593818/ https://www.ncbi.nlm.nih.gov/pubmed/28894283 http://dx.doi.org/10.1038/s41598-017-11583-5 |
Ejemplares similares
-
JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial
por: Cao, Hongbo, et al.
Publicado: (2010) -
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
por: Sun, Xiao, et al.
Publicado: (2015) -
JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice
por: Cao, Ying, et al.
Publicado: (2019) -
The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway
por: Li, Siming, et al.
Publicado: (2022) -
Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats
por: Jiang, Bingjie, et al.
Publicado: (2018)